Tag: Anti-vascular endothelial growth factor therapy

Advances in subretinal hyperreflective material in neovascular age-related macular degeneration

Authors: Liang Congbi,  Chen Changzheng DOI: 10.3760/cma.j.cn115989-20211228-00717 Published 2024-05-10 Cite as Chin J Exp Ophthalmol, 2024, 42(5): 487-490. Abstract                              [Download PDF] [Read Full Text] Subretinal hyperreflective material (SHRM) is a morphologic feature seen on optical coherence tomography as hyperreflective material outside the […]

Research progress of anti-VEGF for the therapy in wet age-related macular degeneration

Authors: Liu Shu,  Xu Xiaofang DOI: 10.3760/cma.j.issn.2095-0160.2018.12.013 Published 2018-12-10 Cite as Chin J Exp Ophthalmol, 2018,36(12): 962-966. Abstract                              [Download PDF] [Read Full Text] Age-related macular degeneration (AMD) is the primary cause of the blindness among the population aged more than 50 years old.The […]

Research progress of anti-VEGF for the therapy in wet age-related macular degeneration

Authors: Liu Shu,  Xu Xiaofang DOI: 10.3760/cma.j.issn.2095-0160.2018.12.013 Published 2018-12-10 Cite as Chin J Exp Ophthalmol, 2018,36(12): 962-966. Abstract Age-related macular degeneration (AMD) is the primary cause of the blindness among the population aged more than 50 years old.The prevalence of AMD increases with age growing.Wet AMD is the main cause of the visual impairment in over 90% […]